Weiwei Lin
Impact in
-
- Curcumin's Biomedical Applications
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 3
- Natural product bioactivities and synthesis 2
- RNA Research and Splicing 2
- RNA regulation and disease 2
- Oncology 6
- Co-authors
- Pengcheng Yan (5 shared papers)Jianyong Dong (5 shared papers)Qi Wang (1 shared paper)Tianfei Lu (1 shared paper)Ning Xu (1 shared paper)Chuan Shen (1 shared paper)Taihua Yang (1 shared paper)Qiang Xia (1 shared paper)
- Journals
- Cell Reports Medicine (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Biomedical Nanotechnology (1 paper)Journal of Ethnopharmacology (1 paper)Cancers (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Weiwei Lin
31 papers receiving 422 citations
Peers
Comparison fields: 5 of 90
- Molecular Medicine 28
- Cancer Research 78
- Hepatology 28
- Polymers and Plastics 47
- Molecular Biology 213
Countries citing papers authored by Weiwei Lin
This map shows the geographic impact of Weiwei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Lin more than expected).
Fields of papers citing papers by Weiwei Lin
This network shows the impact of papers produced by Weiwei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Lin. The network helps show where Weiwei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 51 | |
| 2 | 2022 | 28 | |
| 3 | 2020 | 28 | |
| 4 | 2016 | 27 | |
| 5 | 2014 | 23 | |
| 6 | 2019 | 23 | |
| 7 | 2023 | 20 | |
| 8 | 2003 | 20 | |
| 9 | 2021 | 19 | |
| 10 | 2008 | 18 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2015 | 14 | |
| 16 | 2017 | 14 | |
| 17 | 2023 | 13 | |
| 18 | 2013 | 13 | |
| 19 | 2010 | 11 | |
| 20 | 2020 | 9 |
About Weiwei Lin
Weiwei Lin is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 32 papers that have together received 430 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Glioma Diagnosis and Treatment (3 papers), Nanoplatforms for cancer theranostics (2 papers), Natural product bioactivities and synthesis (2 papers), Corrosion Behavior and Inhibition (2 papers), RNA Research and Splicing (2 papers), Polymer Nanocomposites and Properties (2 papers) and RNA regulation and disease (2 papers). The work is most often cited by research in Molecular Medicine (28 citations), Cancer Research (78 citations), Hepatology (28 citations), Polymers and Plastics (47 citations) and Molecular Biology (213 citations). Weiwei Lin has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Pengcheng Yan, Jianyong Dong, Qi Wang, Tianfei Lu, Ning Xu, Chuan Shen, Taihua Yang, Qiang Xia, Guangxiang Gu and Haishan Huang. Their work appears in journals such as Cell Reports Medicine, Bioorganic & Medicinal Chemistry Letters, Journal of Biomedical Nanotechnology, Journal of Ethnopharmacology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.